For the Inventor, By the Inventor

Enter inventor name

Wei Chen

USPTO Granted Patents = 46 (Patent Applications = 31)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Xuzhou, CN (2019 - 2021)
Dongguan, CN (2013 - 2023)
Jiangsu, CN (2015 - 2023)
Quanzhou, CN (2023)
Zhenjiang, CN (2023)
Nuxi, CN (2023)
Nanjing, CN (2017 - 2024)
Shanghai, CN (2024)
Fuzhou, CN (2024)

Company Filing History:

13 out of 27,246

Huawei Technologies Co., Limited

Nanjing University

4. 3 out of 269

Stanley Black Decker, Inc.

5. 3 out of 285

China University of Mining and Technology (CUMT)

6. 3 out of 346

Jiangsu University

Qyuns Therapeutics Co., Ltd.

8. 2 out of 528

Jiangnan University

Dongguan Amperex Technology Limited

10. 1 out of 148

Nanjing University of Aeronautics and Astronautics

11. 1 out of 448

Shandong University

12. 1 out of 4,408

Guangdong Oppo Mobile Telecommunications Corp., Ltd.

Jiangsu Hhck Advanced Materials Co., Ltd.

Hansong (nanjing) Technology Ltd.

Rajax Network Technology (shanghai) Co., Ltd.

Jiangsu Qyuns Therapeutics Co., Ltd.

17. 1 out of 64

Shanghai University

Wuxi Huashunminsheng Food Co. Ltd.

Anjoy Foods Group Co., Ltd.

Hubei Anjoy Food Co. Ltd.

High Hope Zhongding Corporation

Suzhou Kunpeng Biotech Co., Ltd.

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Aminoacyl-tRNA Synthetase

Photonic Orbital Angular Momentum

Wireless Charging

Microwave Processing

Chiral Cell Structures

Unmanned Delivery Devices

Heat Sink Technology

Network Routing Configurations

Variable Compression Ratio Engines

Calorimetry Techniques

Optical Flow Tracking

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454715 - Aminoacyl-tRNA synthetase efficiently introducing lysine derivatives (2025-10-28),

2. 12378309 - Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use thereof to treat disease (2025-08-05),

3. 12351626 - Anti-human interleukin-33 monoclonal antibody and use thereof (2025-07-08),

4. 12297280 - Monoclonal antibodies against human interleukin-4 receptor alpha, encoding nucleic acids thereof and method of use thereof to treat IL-4 or IL-4/IL-13-mediated diseases (2025-05-13),

5. 12251862 - Metal-resin composite, surface treatment method, and substrate of circuit board for high-frequency and high-speed signal transmission (2025-03-18),

6. 12229039 - On-demand contextual trace log generation (2025-02-18),

7. 12225279 - Input method and electronic device (2025-02-11),

8. 12169302 - Bending-resistant low-crosstalk photonic orbital angular momentum fiber waveguide (2024-12-17),

9. 12147450 - Efficient real-time hierarchy using change events (2024-11-19),

10. 12110323 - Anti-human interleukin 17A monoclonal antibody and application thereof (2024-10-08),

11. 12107771 - Efficient reporting of system resource health status (2024-10-01),

12. 12099973 - Computer system and method to efficiently extend a workflow in software (2024-09-24),

13. 12088365 - EIRP control method, communications apparatus, and communications system (2024-09-10),

14. 12047107 - Communication apparatus (2024-07-23),

15. 12045768 - Unmanned delivery device, delivery robot dispatching method, and electronic device (2024-07-23),

Title: Inventor Wei Chen - Revolutionizing Technology in Jiangsu

Introduction: Wei Chen is a visionary inventor based in Jiangsu, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Wei Chen holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Wei Chen has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Wei Chen has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing to drive progress in the tech sector.

Conclusion: Wei Chen's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Jiangsu and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…